During the past decade, Kendle International Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kendle International Inc." are "Healthy" (67 trials) and "Healhty" (1 trials). Many other conditions were trialed in "Kendle International Inc." in a lesser frequency.

Most popular intervention types in "Kendle International Inc." are "Drug" (68 trials). Other intervention types were less common.

The name of intervention was led by "Ditropan XL® Tablets 10 mg" (3 trials), "Midodrine HCl Tablets 5 mg" (3 trials), "Oxybutynin Chloride ER Tablets 10 mg" (3 trials), "ProAmatine® Tablets 5 mg" (3 trials) and "Topiramate Sprinkle Capsules 25 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kendle International Inc." are 63 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kendle International Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Kendle International Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kendle International Inc., 68 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".